Drugs / Galactooligosaccharide
Galactooligosaccharide
also known as
GOS · B galacto-oligosaccharides · Bimuno Travelaid · galactooligosaccharides · Galactooligossacharides
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02183766 | Apr 2010 → Mar 2012 | constipation disorder | University of Campinas, Brazil | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02953691 | Jun 2017 → Jan 2018 | anxiety | Jeff Taekman, M.D. | Withdrawn | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT05354310 | Feb 2022 → Feb 2024 | — | Leiden University Medical Center | Unknown | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Galactooligosaccharide | “Participants will be given dietary supplement powder containing protein, galactooligosaccharide (GOS), vitamin D, and calcium throughout the twelve weeks of intervention.” NCT05354310 ↗ |
| Known as | B galacto-oligosaccharides | “prebiotics GOS (trade name: Bimuno Travelaid; generic name:B galacto-oligosaccharides)” NCT02953691 ↗ |
| Known as | Bimuno Travelaid | “prebiotics GOS (trade name: Bimuno Travelaid; generic name:B galacto-oligosaccharides)” NCT02953691 ↗ |
| Known as | galactooligosaccharides | “evaluate the effect of galactooligosaccharides (GOS) on functional constipation in children and adolescents.” NCT02183766 ↗ |
| Known as | Galactooligossacharides | “This clinical trial aimed to evaluate the effect of Galactooligossacharides (GOS) on constipated children.” NCT02183766 ↗ |
| Known as | GOS | “Participants will be given dietary supplement powder containing protein, galactooligosaccharide (GOS), vitamin D, and calcium throughout the twelve weeks of intervention.” NCT05354310 ↗1“evaluate the effect of galactooligosaccharides (GOS) on functional constipation in children and adolescents.” NCT02183766 ↗ |
| Modality | Other / unclassified | “administration of the prebiotics GOS” NCT02953691 ↗ |
| Route | Oral | “the solution was ingested for 30 days” NCT02183766 ↗ |